The impact of genetic factors on the incidence of multiple primary tumors (MPT) of the head and neck

Cancer Letters

Volumn 224, Issue 2, 2005, Pages 263-278

  Rydzanicz, Małgorzata ^a   Wierzbicka, Małgorzata ^b   Gajȩcka, Marzena ^a   Szyfter, Witold ^b   Szyfter, Krzysztof ^a,b  

^a INSTITUTE OF HUMAN GENETICS   (Poland)

^b POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Genetic factor; Genotyping; Head and neck cancer; Multiple primary tumors

Indexed keywords

ARYLAMINE ACETYLTRANSFERASE; CARCINOGEN; CYTOCHROME P450 1A1; CYTOCHROME P450 2E1; GLUTATHIONE TRANSFERASE; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE M3; GLUTATHIONE TRANSFERASE T1; PROTEIN; UNCLASSIFIED DRUG; X RAY REPAIR CROSS COMPLEMENTING GROUP 1 PROTEIN; X RAY REPAIR CROSS COMPLEMENTING GROUP 3 PROTEIN; XERODERMA PIGMENTOSUM GROUP D PROTEIN;

ADULT; AGED; ARTICLE; CANCER GENETICS; CANCER INCIDENCE; CANCER RISK; CANCER SUSCEPTIBILITY; CIGARETTE SMOKING; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA REPAIR; EXON; FEMALE; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENOTYPE; HEAD AND NECK CANCER; HEREDITY; HUMAN; MALE; MULTIPLE CANCER; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

AGED; CASE-CONTROL STUDIES; ENZYMES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HEAD AND NECK NEOPLASMS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASMS, MULTIPLE PRIMARY; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC;

EID: 19444369255     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2005.01.015     Document Type: Article

References (62)

1. J.L. Gluckman, and J.D. Crissman Survival rates in 548 patients with multiple neoplasms of the upper aerodigestive tract Laryngoscope 93 1983 71 74
2. A.S. Jones, P. Morar, D.E. Philips, J. Field, D. Husband, and T.R. Helliwell Second primary tumors in patients with head and neck squamous cell carcinoma Cancer 75 1995 1343 1353
3. B. Kulczynski, M. Pruszewicz, and M. Wierzbicka Incidence of second primary malignant neoplasms in patients treated for laryngeal cancer Otolaryngol. Pol. 49 1995 322 328 (Polish)
4. G.B. Snow Follow-up in patients treated for head and neck cancer: how frequent, how thorough and for how long? Eur. J. Cancer 28 1992 315 316
5. W. Zatonski, H. Becher, J. Lissowska, and J. Wahrendorf Tobacco, alcohol and diet in etiology of laryngeal cancer: a population-based case-control study Cancer Causes Control 2 1991 3 10
6. W.J. Blot, J.K. McLaughlin, D.M. Winn, D.F. Austin, R.S. Greenberg, and S. Preston-Martin Smoking and drinking in relation to oral and pharyngeal cancer Cancer Res. 48 1988 3282 3287
7. F. Lewin, S. Norell, H. Johansson, P. Gustavsson, J. Wennerberg, and A. Biorklund Smoking tobacco, oral snuff, and alcohol in the etiology of squamous cell carcinoma of the head and neck: a population-based case-referent study in Sweden Cancer 82 1998 1367 1375
8. H. Maier, A. Dietz, U. Gewelke, W. Heller, and H. Weidauer Tobacco and alcohol and the risk of head and neck cancer Clin. Invest. 70 1992 320 327
9. J. Muscat, and E. Wynder Tobacco, alcohol, asbestos, and occupational risk factors for laryngeal cance Cancer 69 1992 2244 2251
10. F. Cianfriglia, D.A. Di Gregorio, and A. Manieri Multiple primary tumors in patients with oral squamous cell carcinoma Oral Oncol. 35 1999 157 163
11. G.L. Day, W.J. Blot, R.E. Shore, J.K. McLaughlin, D.F. Austin, and R.S. Greenberg Second cancer following oral and pharyngeal cancers: role of tobacco and alcohol J. Natl Cancer Inst. 8 1994 131 137
12. T. Hiyama, T. Sato, K. Yoshino, H. Tsukuma, A. Hanai, and I. Fujimoto Second primary cancer following laryngeal cancer with special reference to smoking habits Jpn. J. Cancer Res. 83 1992 334 339
13. E.L. Wynder, M.H. Mushinsky, and J.C. Spivak Tobacco and alcohol consumption in relation to the development of multiple primary cancers Cancer 40 1977 1872 1878
14. International Agency for Research on Cancer /IARC/(1986) Tobacco Smoking. IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Human 1986 IARC Lyon
15. L. Ernest, H. Esumi, Y. Fujii, H.V. Gelboin, R. Kato, and T. Sugimura Xenobiot and Cancer 1991 Japan Scientific Societies Press Tokyo, Japan pp. 1-38
16. H. Bartsch, and E. Hietanen The role of individual susceptibility in cancer burden related to environmental exposure Environ. Health Perspect. 104 1996 1996
17. N. Jourenkova-Mironova, H. Wikman, C. Bouchardy, K. Mitrunen, P. Dayer, S. Benhamous, and A. Hirvonen Role of arylamine N-acetyltransferase 1 and 2 (NAT1 and NAT2) genotypes in susceptibility to oral/pharyngeal and laryngeal cancer Pharmacogenetics 9 1999 533 537
18. C. Matthias, U. Bockmuhl, V. Jahnke, P. Jones, J. Hayes, and J. Alldersea Polymorphism in cytochrome P450 CYP2D6, CYP1A1, CYP2E1 and glutathione S-transferase, GSTM1, GSTM3, GSTT1 and susceptibility to tobacco-related cancers: studies in upper aerodigestive tract cancers Pharmacogenetics 8 1998 91 100
19. A.F. Olshan, M.C. Weissler, M.A. Watson, and D.A. Bell GSTM1, GSTT1, GSTP1, CYP1A1, and NAT1 polymorphisms, tobacco use, and the risk of head and neck cancer Cancer Epidemiol. Biomarkers Prev. 9 2000 185 191
20. G. Matullo, D. Palli, M. Peluso, S. Guarrera, S. Carturan, and E. Celentano XRCC1, XRCC3, XPD gene polymorphisms, smoking and (32)P-DNA adducts in a sample of healthy subjects Carcinogenesis 22 2001 1437 1445
21. E.M. Sturgis, E.J. Castillo, L. Li, R. Zheng, S.A. Eicher, and G.L. Clayman Polymorphisms of DNA repair gene XRCC1 in squamos cell carcinoma of the head and neck Carcinogenesis 20 1999 2125 2129
22. D. Butkiewicz, M. Rusin, L. Enewold, P.G. Shields, M. Chorazy, and C.C. Harris Genetic polymorphisms in DNA repair genes and risk of lung cancer Carcinogenesis 22 2001 593 597
23. J. To-Figueras, M. Gene, J. Gómez-Catalan, M. Galan, M. Fuentes, and J. Ramon Glutathione S-transferase M1 (GSTM1) and T1 (GSTT1) polymorphisms and lung cancer risk among Northwestern Mediterranean's Carcinogenesis 18 1997 1529 1533
24. I. Cascorbi, J. Brockmoller, and I. Roots A C4887A polymorphism in exon 7 of human CYP1A1: population frequency, mutation linkages, and impact of lung cancer susceptibility Cancer Res. 56 1996 4965 4969
25. I. Cascorbi, J. Brockmoller, P. Mrozikiewicz, S. Bauer, R. Loddenkemper, and I. Roots Homozygous rapid arylamine N-acetyltransferase (NAT2) genotype as a susceptibility factor for lung cancer Cancer Res. 56 1996 3961 3966
26. E.M. Sturgis, R. Zheng, L. Li, E.J. Castillo, S.A. Eicher, and M. Chen XPD/ERCC2 polymorphisms and risk of head and neck cancer: a case-control analysis Carcinogenesis 21 2000 2219 2223
27. C. Kiyohara, Y. Nakanishi, S. Inutsuka, K. Takayama, N. Hara, and A. Motohiro The relationship between CYP1A1 aryl hydrocarbon hydroxylase activity and lung cancer in Japan population Pharmacogenetics 8 1998 315 323
28. T. Okada, K. Kawashima, S. Fukushi, T. Minakuchi, and S. Nishimura Association between a cytochrome P450 CYP1A1 genotype and incidence of lung cancer Pharmacogenetics 4 1994 333 340
29. K. Nakachi, K. Imai, S. Hayashi, and K. Kawajiri Polymorphism of the CYP1A1 and gluthatione S-transferase genes associated with susceptibility to lung cancer in relation to cigarette dose in a Japanese population Cancer Res. 53 1993 2994 2999
30. K. Tanimoto, H. Yoshiga, and T. Ichikawa Polymorphisms of CYP1A1 and GSTM1 gene involved in oral squamous cell carcinoma in association with cigarette dose Oral Oncol. 35 1999 191 196
31. P.G. Shields, N.E. Caporaso, R.T. Falk, H. Sugimura, G.E. Trivers, and B.F. Trump Lung cancer, race, and a CYP1A1 genetic polymorphism Cancer Epidemiol. Biomarkers Prev. 2 1993 481 485
32. C. Bouchardy, H. Wikman, S. Benhamou, A. Hirvonen, P. Dayer, and K. Husgafvel-Pursiainen CYP1A1 genetic polymorphisms, tobacco smoking and lung cancer risk in French Caucasian population, Biomarkers 2 1997 131 134
33. M. Rojas, I. Cascorbi, K. Alexandrov, E. Kriek, G. Auburtin, and L. Mayer Modulation of benzo(a)pyrene diolepoxide-DNA adduct levels in human white blood cells by CYP1A1, GSTM1 and GSTT1 polymorphism Carcinogenesis 21 2000 35 41
34. S. Hayashi, J. Watanabe, and K. Kawajiri Genetic polymorphisms in the 5′ -flanking region change transcriptional regulation of the human cytochrome P450IIE1 gene J. Biochem. 110 1991 559 565
35. S. Pemble, K.R. Schroeder, S.R. Spencer, D.J. Mayer, E. Hallier, and H.M. Blot Human glutathione S-transferase theta (GSTT1): cDNA cloning and the characterization of a genetic polymorphism Biochem. J. 300 1994 271 276
36. H.C. Hung, and Y.C. Chien Genetic polymorphisms of CYP2E1, GSTM1 and GSTT1; environmental factors and risk of oral cancer Cancer Epidemiol. Biomarkers Prev. 6 1997 901 905
37. K.T. Kelsey, M.R. Spitz, Z.F. Zuo, and J.K. Wiencke Polymorphism in the glutatione S-transferase class mu and theta genes interact and increase susceptibility to lung cancer in minority population Cancer Causes Control 8 1997 554 559
38. S.T. Saarikoski, C. Bouchardy, H. Wikman, P. Dayer, S. Benhamou, and A. Hirvonen Combined effect of polymorhic GST genes on individual susceptibility to lung cancer Int. J. Cancer 77 1998 516 521
39. N. Jourenkova-Mironova, H. Wikman, C. Bouchardy, A. Voho, P. Dayer, and S. Benhamou Role of glutathione S-transferase GSTM1, GSTM3, GSTP1 and GSTT1 genotypes in modulating susceptibility to smoking-related lung cancer Pharmacogenetics 8 1998 495 502
40. L. Cheng, E.M. Sturgis, S.A. Eicher, D. Char, M.R. Spitz, and Q. Wei Glutathione-S-transferase polymorphisms, and risk of squamous- cell carcinoma of the head and neck Int. J. Cancer 84 1999 220 224
41. N. Hamel, S. Karimi, M.N. Hebert-Blouin, J.S. Brunet, B. Gilfix, and P. Ghadirian Increased risk of head and neck cancer in association with GSTT1 nullizygosity for individuals with low exposure to tobacco Int. J. Cancer 87 2000 452 454
42. C. Matthias, V. Jahnke, A.A. Fryer, and R.C. Strange First results on the influence of polymorphisms at glutathione S-transferase, cytochrome P450, and tumor necrosis factor gene loci on the development of multiple head and neck cancer Laryngorhinootologie 82 2003 25 30
43. S. Jhavar, R. Sarin, R. Mulherkar, A. Benner, J.P. Agarwal, and K. Dinshaw Glutathione S-transferase M1 or T1 null genotype as a risk factor for developing multiple primary neoplasms in the upper aero-digestive tract, in Indian males using tobacco Oral Oncol. 40 2004 84 91
44. J.Y. Park, J.E. Muscat, Q. Ren, S.P. Schantz, R.D. Harwick, and J.C. Stern CYP1A1 and GSTM1 polymorphisms and oral cancer risk Cancer Epidemiol. Biomarkers Prev. 6 1997 791 797
45. N. Jourenkova-Mironova, A. Voho, C. Bouchardy, H. Wikman, P. Dayer, S. Benhamou, and A. Hirvonen Glutathione S-transferase GSTM3 and GSTP1 genotypes and larynx cancer risk Cancer Epidemiol. Biomarkers Prev. 8 1999 185 188
46. Z. Trizna, G.L. Clayman, M.R. Spitz, K.L. Briggs, and H. Goepfert Glutathione S-transferase genotypes as risk factors for head and neck cancer Am. J. Surg. 170 1995 499 501
47. N. Jourenkova-Mironova, A. Voho, C. Bouchardy, H. Wikman, P. Dayer, and S. Benhamou Glutathione S-transferase GSTM1, GSTM3, GSTP1 and GSTT1 genotypes and the risk of smoking-related oral and pharyngeal cancers Int. J. Cancer 81 1999 44 48
48. M.V. Gonzalez, M.F. Pello, M.J. Menendez, C. Suarez, and E. Coto Genetic polymorphism of N-acetylotransferase-2, glutation S-transferase M1 and cytochromes P450IIE1 and P450IID6 in the susceptibility to head and neck cancer J. Clin. Pathol. 51 1998 294 298
49. T. Katoh, S. Kaneko, K. Kohshi, M. Munaka, K. Kitagawa, and N. Kunugita Genetic polymorphisms of tobacco- and alcohol-related metabolizing enzymes and oral cavity cancer Int. J. Cancer 83 1999 606 609
50. V.A. Smelt, H.J. Mardon, and E. Sim Placental expresion of arylamine N-acetyltransferase: evidence ror linkage disequilibrium between NAT1*10 and NAT2*4 alleles of the two human N-acetyltransferase loci NAT1 and NAT2 Pharmacol. Toxicol. 83 1998 149 157
51. I. Cascorbi, S. Henning, J. Brockmoller, J. Gephart, C. Meisel, and J.M. Muller Substantially reduced risk of cancer of the aerodigestive tract in subject with variant 463A of the myeloperoxidase gene Cancer Res. 60 2000 644 649
52. M.C. Stern, D.M. Umbach, R.M. Lunn, and J.A. Taylor DNA repair gene XRCC3 codon 241 polymorphism, its interaction with smoking and XRCC1 polymorphisms, and bladder cancer risk Cancer Epidemiol. Biomarkers Prev. 11 2002 939 943
53. H. Shen, E. Sturgis, K. Dahlstrom, Y. Zheng, M. Spitz, and Q. Wei A variant of the DNA repair gene XRCC3 and risk of squamous cell carcinoma of the head and neck: a case-control analysis Int. J. Cancer 99 2002 869 872
54. J.Y. Park, S.Y. Lee, H.S. Jeon, N.C. Bae, S.C. Chae, S. Joo, and T.H. Jung Polymorphism of the DNA repair gene XRCC1 and risk of primary lung cancer Cancer Epidemiol. Biomarkers Prev. 11 2002 23 27
55. H.N.U. Bartsch, U. Nair, A. Risch, M. Rojas, H. Wikman, and K. Alexandrov Genetic polymorphism of CYP genes alone or in combination as a risk modifiers of tobacco related cancer Cancer Epidemiol. Biomarkers Prev. 9 2000 3 28
56. K. Nakachi, K. Imai, S. Hayaski, and K. Kawajiri Polmorphism of the CYP1A1 and glutatione S-transferase genes associated with susceptibility to lung cancer in relation to cigarette dose in a Japanese population Cancer Res. 53 1993 2994 2999
57. R.J. Hung, P. Boffetta, J. Brockmoller, D. Butkiewicz, I. Cascorbi, and M.L. Clapper CYP1A1 and GSTM1 genetic polymorphisms and lung cancer risk in Caucasian non-smokers: a pooled analysis Carcinogenesis 24 2003 875 882
58. K. Tanimoto, S. Hayashi, K. Yoshiga, and T. Ichikawa Polymorphisms of CYP1A1 and GSTM1 gene involved in oral squamous cell carcinoma in association with cigarette dose Oral Oncol. 35 1999 191 196
59. E. Taioli, L. Gaspari, S. Benhamou, P. Boffetta, J. Brockmoller, and D. Butkiewicz Polymorphisms in CYP1A1, GSTM1, GSTT1 and lung cancer below the age of 45 years Int. J. Epidemiol. 32 2003 60 63
60. V. Bongers, B.J. Braakhuis, H. Tobi, H. Lubsen, and G.B. Snow The relation between cancer incidence among relatives and the occurrence of multiple primary carcinomas following head and neck cancer Cancer Epidemiol. Biomarkers Prev. 5 1996 595 598
61. Y. Zhu, M.R. Spitz, T.C. Hsu, and X. Wu Genetic instability of specific chromosomes associated with a family history of cancer Cancer Genet. Cytogenet. 136 2002 73 77
62. D.G. Miller, R. Tiwari, S. Pathak, V.L. Hopwood, F. Gilbert, and T.C. Hsu DNA repair and mutagen sensitivity in patients with triple primary cancers Cancer Epidemiol. Biomarkers Prev. 7 1998 321 327